Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1050831

registered interest
date	29/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what commitments they will make to ensure that the UK's 3.7 million diagnosed diabetics will have access to sufficient stockpiles of medication to avoid potential deaths from diabetic ketoacidosis in the event of a no-deal Brexit.
tabling member printed	Lord Roberts of Llandudno
uin	HL13252
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>The Department understand that diabetes medicines and medical radiopharmaceuticals are vitally important to many people in this country. Our ‘no deal’ contingency plans include mitigations for medicines that come to the United Kingdom from or via the European Union or European Economic Area (EEA), including precautionary stockpiling by suppliers and securing alternative shipping routes to ensure the flow of medicines, to ensure that the supply of diabetes medicines, medical radioisotopes and other essential medicines to patients is not disrupted.</p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU/EEA asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p>We recognise that certain medicines with short shelf lives, including medical radiopharmaceuticals or medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure that they have plans in place in advance plans to air freight these medicines from the EU in the event of a ‘no deal’ exit.</p><p> </p><p>While the stockpiling medicines and alternative air freight remains a critical part of our ‘no deal’ medicine supply contingency plans, we are also supplementing these with additional actions.</p><p>We are working towards ensuring we have sufficient roll-on, roll-off freight capacity on alternative routes to enable these vital products to continue to move freely in to the UK. Medicines and medical products, including diabetes medicines, will be prioritised on these routes to ensure that the flow of all these products will continue unimpeded after 29 March 2019.</p><p>Throughout enacting our plans, we have received very good engagement from industry who share our aims of ensuring that the continuity of supply of medicines and medical products for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL13253 HL13254 question first answered 11/02/2019 17:57:28 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3691 label Biography information for Lord Roberts of Llandudno

1050833

registered interest
date	29/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how they will ensure the supply of radiopharmaceuticals in the event of a no-deal Brexit; and what steps they will take to prevent delays in the treatment of patients with serious conditions.
tabling member printed	Lord Roberts of Llandudno
uin	HL13253
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>The Department understand that diabetes medicines and medical radiopharmaceuticals are vitally important to many people in this country. Our ‘no deal’ contingency plans include mitigations for medicines that come to the United Kingdom from or via the European Union or European Economic Area (EEA), including precautionary stockpiling by suppliers and securing alternative shipping routes to ensure the flow of medicines, to ensure that the supply of diabetes medicines, medical radioisotopes and other essential medicines to patients is not disrupted.</p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU/EEA asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p>We recognise that certain medicines with short shelf lives, including medical radiopharmaceuticals or medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure that they have plans in place in advance plans to air freight these medicines from the EU in the event of a ‘no deal’ exit.</p><p> </p><p>While the stockpiling medicines and alternative air freight remains a critical part of our ‘no deal’ medicine supply contingency plans, we are also supplementing these with additional actions.</p><p>We are working towards ensuring we have sufficient roll-on, roll-off freight capacity on alternative routes to enable these vital products to continue to move freely in to the UK. Medicines and medical products, including diabetes medicines, will be prioritised on these routes to ensure that the flow of all these products will continue unimpeded after 29 March 2019.</p><p>Throughout enacting our plans, we have received very good engagement from industry who share our aims of ensuring that the continuity of supply of medicines and medical products for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL13252 HL13254 question first answered 11/02/2019 17:57:28 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3691 label Biography information for Lord Roberts of Llandudno

1050834

registered interest
date	29/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they will take to ensure that every prescription for medication can still be redeemed in the event of a no-deal Brexit.
tabling member printed	Lord Roberts of Llandudno
uin	HL13254
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>The Department understand that diabetes medicines and medical radiopharmaceuticals are vitally important to many people in this country. Our ‘no deal’ contingency plans include mitigations for medicines that come to the United Kingdom from or via the European Union or European Economic Area (EEA), including precautionary stockpiling by suppliers and securing alternative shipping routes to ensure the flow of medicines, to ensure that the supply of diabetes medicines, medical radioisotopes and other essential medicines to patients is not disrupted.</p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU/EEA asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p>We recognise that certain medicines with short shelf lives, including medical radiopharmaceuticals or medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure that they have plans in place in advance plans to air freight these medicines from the EU in the event of a ‘no deal’ exit.</p><p> </p><p>While the stockpiling medicines and alternative air freight remains a critical part of our ‘no deal’ medicine supply contingency plans, we are also supplementing these with additional actions.</p><p>We are working towards ensuring we have sufficient roll-on, roll-off freight capacity on alternative routes to enable these vital products to continue to move freely in to the UK. Medicines and medical products, including diabetes medicines, will be prioritised on these routes to ensure that the flow of all these products will continue unimpeded after 29 March 2019.</p><p>Throughout enacting our plans, we have received very good engagement from industry who share our aims of ensuring that the continuity of supply of medicines and medical products for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL13252 HL13253 question first answered 11/02/2019 17:57:28 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3691 label Biography information for Lord Roberts of Llandudno

1050835

registered interest
date	29/01/2019
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	Italy: Asylum
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what actions, if any, they are taking to bring Brendan Woodhouse, his crew, and the 47 rescuees on their vessel who are currently detained off the coast of Italy to the UK.
tabling member printed	Lord Roberts of Llandudno
uin	HL13255
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>​Sea-Watch 3 disembarked the 47 rescued migrants on board at Catania (Sicily) on 31 January.</p> answering member printed Lord Ahmad of Wimbledon question first answered 11/02/2019 14:28:29 answering member 4210 label Biography information for Lord Ahmad of Wimbledon
tabling member	3691 label Biography information for Lord Roberts of Llandudno

1050836

registered interest
date	29/01/2019
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	Brazil: Floods
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assistance, if any, they have provided to the victims of the recent mud flow in Minas Gerais, Brazil.
tabling member printed	Lord Roberts of Llandudno
uin	HL13256
answer	answer is ministerial correction date of answer 06/02/2019 answer text <p>No requests for assistance from HMG have been received. Our embassy is in contact with local authorities who are doing all that they can to help those affected. Our consulate in Belo Horizonte is in contact with British stakeholders that could provide assistance.</p> answering member printed Lord Bates question first answered 06/02/2019 17:37:03 answering member 1091 label Biography information for Lord Bates
tabling member	3691 label Biography information for Lord Roberts of Llandudno

1036910

registered interest
date	07/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to ensure that the supply of medicines into the UK will not be disrupted as a result of Brexit; and what is the cost of any such steps.
tabling member printed	Lord Roberts of Llandudno
uin	HL12552
answer	answer is ministerial correction date of answer 21/01/2019 answer text <p>The Government has now agreed the Withdrawal Agreement with the European Commission, which includes an implementation period that will run from March 2019 until December 2020. During this time, the supply of medicines will remain unchanged. As a responsible Government, however, we continue to prepare proportionately for all scenarios, including ‘no deal’.</p><p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription only medicines and pharmacy medicines to the United Kingdom that come from, or via, the European Union or European Economic Area (EEA) asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p>We have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit. In the light of this engagement, the Department is currently considering how best it may support those companies taking part in the contingency planning.</p><p>Additionally, a tender process to procure additional warehouse space for stockpiled medicines, including ambient, refrigerated and controlled drug storage, was undertaken in October 2018. Contract agreements for storage have recently been signed or are imminent. This is expected to cost the Government in the low tens of millions of pounds.</p><p>Whilst the six-week stockpiling activity remains a critical part of our contingency plans, this has been supplemented with additional actions. The Government recognises the importance of medicines and is working to ensure that there is sufficient roll-on, roll-off freight capacity to enable these vital products to continue to move freely in to the UK from 29 March in a ‘no deal’ scenario. The Department is working closely with the Department for Transport to ensure all medicines and medical products are prioritised on these alternative routes to ensure that the flow of all these products will continue unimpeded after 29 March 2019.</p><p>On 7 December 2018, the Department wrote to pharmaceutical companies that supply licensed medicines to the UK from or via the EU/EEA, and/or manufacture medicines in the UK, informing them of the updated reasonable worst-case scenario border planning assumptions and asking them about their current transportation routes and their ability to re-route their supply chains if they currently rely on Dover and/or Folkestone. Since then we have been working closely with those companies to better understand their supply chains and the potential for rerouting in a ‘no deal’ scenario.</p><p> </p> answering member printed Baroness Manzoor question first answered 21/01/2019 16:25:51 answering member 4289 label Biography information for Baroness Manzoor
tabling member	3691 label Biography information for Lord Roberts of Llandudno